Introduction
To provide a multidisciplinary platform for leading experts in thoracic oncology to share the latest advances in diagnosis, treatment, and research of thoracic malignancies. The event aims to foster collaboration, stimulate discussion, and strengthen regional and global networks to improve patient care and outcomes in thoracic cancer.
- Analyse the application of personalised lung cancer care by critically evaluating the latest NCCN guidelines, tumour molecular profiling, and MDT approaches to develop tailored treatment plans that optimise patient outcomes
- Evaluate the efficacy of advanced therapies, including stereotactic body radiotherapy (SBRT), minimally invasive surgical approaches, oncological targeted therapies etc. through the assessment of real case studies to determine their impact on early-stage and complex lung cancer cases
- Synthesise regional and global best practices in lung cancer care by fostering collaboration and networking, enabling attendees to apply these insights to enhance the standard of care and patient access to innovative treatments across the GCC.